[ad_1]
Scientific advisers have sent the government their recommendations for who should be offered a COVID booster jab this autumn.
Experts from the Joint Committee on Vaccination and Immunisation (JCVI) say the extra shot would help maintain protection over the winter against severe COVID-19.
It recommends jabs for:
- Over 65s
- Care home residents and staff
- Frontline health and social care workers
- People over 16 in vulnerable groups
The “interim advice” from the Joint Committee on Vaccination and Immunisation (JCVI) is intended to help the NHS plan for later in the year.
It’s possible more people could be added to the above groups.
The JCVI said it would continue assessing the situation “in relation to the timing and value of doses for less vulnerable older adults”.
Final plans will be announced later in the year.
Professor Wei Shen Lim, chair of COVID vaccination on the JCVI, said: “Last year’s autumn booster vaccination programme provided excellent protection against severe COVID-19, including against the Omicron variant.
“We have provided interim advice on an autumn booster programme for 2022 so that the NHS and care homes are able to start the necessary operational planning, to enable high levels of protection for more vulnerable individuals and frontline healthcare staff over next winter.
“As we continue to review the scientific data, further updates to this advice will follow.”
If the government accepts the recommendation, it will be some people’s fifth COVID jab.
A spring booster programme has been rolling out a fourth vaccine to over 75s, care home residents, and people over 12 with a weakened immune system.
The UK Health Security Agency said there was “considerable uncertainty with regards to the likelihood, timing and severity of any potential future wave of COVID-19”, but that the greatest threat would still come in winter.
It said the key aim of an autumn booster programme would be to reduce hospitalisations and deaths.
The UK’s latest rolling average for daily coronavirus cases is 8,398; a huge drop from the 180,000-plus daily cases of early January.
For deaths within 28 days of a positive test, the latest daily average is 112; in mid-January it was over 1,200.
[ad_2]